Show simple item record

dc.contributor.authorRajthala, Saroj
dc.contributor.authorParajuli, Himalaya
dc.contributor.authorDongre, Harsh Nitin
dc.contributor.authorLjøkjel, Borghild
dc.contributor.authorHoven, Kristin Marie
dc.contributor.authorKvalheim, Arild
dc.contributor.authorLybak, Stein
dc.contributor.authorNeppelberg, Evelyn
dc.contributor.authorSapkota, Dipak
dc.contributor.authorJohannessen, Anne Christine
dc.contributor.authorCostea, Daniela Elena
dc.date.accessioned2022-08-16T07:03:12Z
dc.date.available2022-08-16T07:03:12Z
dc.date.created2022-05-16T19:01:44Z
dc.date.issued2022-03-17
dc.identifier.issn2234-943X
dc.identifier.urihttps://hdl.handle.net/11250/3011996
dc.description.abstractBackground: Recent studies have shown aberrant expression of micro-RNAs in cancer-associated fibroblasts (CAFs). This study aimed to investigate miR-138 dysregulation in CAFs in oral squamous cell carcinoma (OSCC) and its effects on their phenotype and invasion of adjacent OSCC cells. Methods: Expression of miR-138 was first investigated in OSCC lesions (n = 53) and OSCC-derived CAFs (n = 15). MiR-138 mimics and inhibitors were used to functionally investigate the role of miR-138 on CAF phenotype and the resulting change in their ability to support OSCC invasion. Results: Expression of miR-138 showed marked heterogeneity in both OSCC tissues and cultured fibroblasts. Ectopic miR-138 expression reduced fibroblasts’ motility and collagen contraction ability and suppressed invasion of suprajacent OSCC cells, while its inhibition resulted in the opposite outcome. Transcript and protein examination after modulation of miR-138 expression showed changes in CAF phenotype-specific molecules, focal adhesion kinase axis, and TGFβ1 signaling pathway. Conclusions: Despite its heterogeneous expression, miR-138 in OSCC-derived CAFs exhibits a tumor-suppressive function.en_US
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleMicroRNA-138 abates fibroblast motility with effect on invasion of adjacent cancer cellsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 the authorsen_US
dc.source.articlenumber833582en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fonc.2022.833582
dc.identifier.cristin2024979
dc.source.journalFrontiers in Oncologyen_US
dc.identifier.citationFrontiers in Oncology. 2022, 12, 833582.en_US
dc.source.volume12en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal